Prospective Evaluation of the Use of Intralesional Cryotherapy for Treatment of Keloid and Hypertrophic Scars

N/ACompletedNCT01994616

Amsterdam UMC, location VUmc30 enrolled

Overview

This prospective evaluation studies the effectiveness of IL cryotherapy in treating keloids and hypertrophic scars in a large population of mixed Fitzpatrick skin types.

Intralesional (IL) cryotherapy is a novel treatment for keloids and hypertrophic scars, in which the scar is frozen from inside. Published results are promising, however only Caucasian patient populations have been studied. This prospective evaluation studies the effectiveness of IL cryotherapy in treating keloids and hypertrophic scars in a large population of mixed Fitzpatrick skin types. All patients with keloid or hypertrophic scars meeting inclusion criteria were treated with a liquid nitrogen based device called Cryoshape Scar quality and possible recurrence are assessed pre- and postsurgery (3, 6 and 12 months) with objective devices determine scar color, scar elasticity, scar volume and patient's skin type. In addition, scars are evaluated using the Patient and Observer Scar Assessment Scale.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Keloid Cicatrix, Hypertrophic

Interventions

Intralesional cryotherapyPROCEDURE

Intralesional (IL) cryotherapy is a treatment for keloids and hypertrophic scars, in which the scar is frozen from inside with the use of a cryoneedle

Eligibility

Sex: ALLMin age: 10 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Keloids, defined as excessive scar tissue raised above skin level and proliferating beyond the confines of the original lesion * Hypertrophic scars1 older than 12 months and insensitive to other treatments. Keloids were distinguished from hypertrophic scars based on the clinical judgment of experienced plastic surgeons and on the age of the scar (\>1yr) * A period between previous treatment and IL cryotherapy covered a minimum of 12 weeks * Patients with all Fitzpatrick17 skin types * Patients older than 10 years of age Exclusion Criteria: * pregnancy * diabetes mellitus

Locations (1)

VUmc

Amsterdam, North Holland, Netherlands

Outcomes

Primary Outcomes

Recurrence

Judgment of recurrence, defined as a growing, pruritic, nodular scar

Time frame: 0-12 months

Secondary Outcomes

Scar elasticity

Scar elasticity, measured in two parameters: extension and elasticity

Time frame: 0-12months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.